<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="5017">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03041623</url>
  </required_header>
  <id_info>
    <org_study_id>NEJ030</org_study_id>
    <nct_id>NCT03041623</nct_id>
  </id_info>
  <brief_title>Japanese Idiopathic Interstitial Pneumonias Registry</brief_title>
  <acronym>JIPS</acronym>
  <official_title>Japanese Idiopathic Interstitial Pneumonias Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North East Japan Study Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>North East Japan Study Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An objective of JIPS Registry is to examine disease prevalence of idiopathic interstitial
      pneumonias (IIPs), considering classification, background, and diagnostic methods based on
      American Thoracic Society (ATS)/ European Respiratory Society(ERS) /Japanese Respiratory
      Society (JRS)/ Latin American Thoracic Association (ALAT) guidelines for diagnosis and the
      ATS/ERS classification of 2002 and 2013.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      JIPS Registry is a multi-site, non-interventional, prospective observation study of patients
      with newly diagnosed IIPs in Japan. At least 600 patients will be registered for 16 months
      at approximately 80 sites in Japan.

      Primary research question is to determine the prevalence of each category of IIPs at
      registration, patient background and diagnosis methods will be considered. Furthermore, the
      present treatment patterns and disease behavior (CT and forced vital capacity (FVC) changes,
      as well as changes in interstitial pneumonia markers, etc.) will also be investigated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Data on current practice patterns for diagnosis of IIPs</measure>
    <time_frame>3-4 years</time_frame>
    <description>Describe the frequency of surgical lung biopsy, bronchoalveolar lavage.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of each categorized IIPs</measure>
    <time_frame>3-4 years</time_frame>
    <description>Investigate the prevalence of each categorized IIPs by using a recent guideline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Natural history of each categorized IIPs</measure>
    <time_frame>3-4 years</time_frame>
    <description>Describe the natural history of each categorized IIPs, focusing on CT findings, FVC changes, medications, and causes of death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression-free survival by category of IIPs</measure>
    <time_frame>3-4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital admission for acute exacerbations of IIPs</measure>
    <time_frame>3-4 years</time_frame>
    <description>To evaluate incidences, therapy and prognosis of acute respiratory deterioration in patients with IIPs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change of patient-reported outcome (Saint George Respiratory Questionnaire, COPD assessment test, and Dyspnoea-12) every12 months from baseline</measure>
    <time_frame>3-4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative evaluation of CT findings</measure>
    <time_frame>3-4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Validation of second multidisciplinary discussion</measure>
    <time_frame>3-4 years</time_frame>
    <description>Multidisciplinary discussion (MDD) held by independent central reviewers will be conducted twice at the time of registration and final observation using questionnaire. Concordance rate for diagnosis and disease behavior in each case between the time of registration and final observation will be evaluated.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Idiopathic Interstitial Pneumonia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Newly diagnosed IIPs within 6 months before registration
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients aged between 20 and 84 years

          2. Patients with idiopathic pulmonary fibrosis (IPF) and other IIPs diagnosis within 6
             months before registration at each facility

          3. Patients from whom written informed consent has been obtained regarding participation
             in this study and follow-up observation

        Exclusion Criteria:

          1. Patients for whom the tests (such as the lung function test) conducted in this study
             could not be performed

          2. Patients who underwent pulmonary resection

          3. Patients undergoing dialysis

          4. Patients with cancer treated at the time of registration or those planning to receive
             treatment in the future
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>84 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Takashi Ogura, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kanagawa Cardiovascular and Respiratory Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ryo Okuda, MD</last_name>
    <phone>+81-45-701-9581</phone>
    <email>b980013@yahoo.co.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tosei General Hospital</name>
      <address>
        <city>Seto</city>
        <state>Aichi</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hiroyuki Taniguchi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hiroyuki Taniguchi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kurume University Hospital</name>
      <address>
        <city>Kurume</city>
        <state>Fukuoka</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Masaki Okamoto, MD</last_name>
    </contact>
    <investigator>
      <last_name>Tomoaki Hoshino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sapporo Medical University Hospital</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hirotaka Nishikiori, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hirofumi Chiba, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tokai Univercity Hospital</name>
      <address>
        <city>Isehara</city>
        <state>Kanagawa</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Takahisa Takihara, MD</last_name>
    </contact>
    <investigator>
      <last_name>Koichiro Asano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kanagawa Carciovascular and Respiratory Center</name>
      <address>
        <city>Yokohama</city>
        <state>Kanagawa</state>
        <zip>236-0051</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryo Okuda, MD</last_name>
      <phone>+81-45-701-9581</phone>
      <email>b980013@yahoo.co.jp</email>
    </contact>
    <investigator>
      <last_name>Tomohisa Baba, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Takashi Ogura, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ryo Okuda, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shinshu University Hospital</name>
      <address>
        <city>Matsumoto</city>
        <state>Nagano</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hiroshi Yamamoto, MD</last_name>
    </contact>
    <investigator>
      <last_name>Masayuki Hanaoka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Kinki-chuo Chest Medical Center</name>
      <address>
        <city>Sakai</city>
        <state>Osaka</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yoshikazu Inoue, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yoshikazu Inoue, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hamamatsu University School of Medicine</name>
      <address>
        <city>Hamamatsu</city>
        <state>Shizuoka</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Takafumi Suda, MD</last_name>
      <phone>+81-53-435-2111</phone>
      <email>suda@hama-med.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Yutaro Nakamura, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jichi Medical University</name>
      <address>
        <city>Shimotsuke</city>
        <state>Tochigi</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hiroyoshi Yamauchi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Masashi Bando, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dokkyo Medical University Hospital</name>
      <address>
        <city>Shimotsu</city>
        <state>Tochigi</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yasuo Shimizu, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yoshiki Ishi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chiba University Hospital</name>
      <address>
        <city>Chiba</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mitsuhiro Abe, MD</last_name>
    </contact>
    <investigator>
      <last_name>Kenji Tsushima, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyushu University Hospital.</name>
      <address>
        <city>Fukuoka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Naoki Hamada, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yoichi Nakanishi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hiroshima University Hospital</name>
      <address>
        <city>Hiroshima</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Noboru Hattori, MD</last_name>
    </contact>
    <investigator>
      <last_name>Noboru Hattori, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kochi medical School Hospital</name>
      <address>
        <city>Kochi</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kazushi Takamatsu, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hiroshi Onishi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyoto University Hospital</name>
      <address>
        <city>Kyoto</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tomohiro Handa</last_name>
    </contact>
    <investigator>
      <last_name>Tomohiro Handa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nagasaki University Hospital</name>
      <address>
        <city>Nagasaki</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yuji Ishimoto, ME</last_name>
    </contact>
    <investigator>
      <last_name>Hiroshi Mukae, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nagoya University Hospital</name>
      <address>
        <city>Nagoya</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Naozumi Hashimoto, MD</last_name>
    </contact>
    <investigator>
      <last_name>Naozumi Hashimoto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tokushima University Hospital</name>
      <address>
        <city>Tokushima</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yuko Toyoda, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yasuhiko Nishioka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jikei University Hospital</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hiromichi Hara, MD</last_name>
    </contact>
    <investigator>
      <last_name>Kazuyoshi Kuwano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nippon Medical School Hospital</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hiroki Hayashi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Arata Azuma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toho University Omori Medical Center</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Keishi Sugino, MD</last_name>
    </contact>
    <investigator>
      <last_name>Sakae Homma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tokyo Medical and Dental University</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yukihisa Inoue, MD</last_name>
    </contact>
    <investigator>
      <last_name>Naohiko Inase, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tokyo University Hospital</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hirokazu Urushiyama, MD</last_name>
    </contact>
    <investigator>
      <last_name>Takahide Nagase, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 31, 2017</lastchanged_date>
  <firstreceived_date>December 18, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IIPs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
    <mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
